Improving Lifestyle Behavior by "Joven, Fuerte y Saludable" Multidisciplinary Program.
NCT06090747
Summary
Breast cancer is the leading cause of mortality in women worldwide. Latin-American women are diagnosed at younger ages, in advanced stages, and with aggressive molecular subtypes. Lifestyle seems related to these aggressive conditions and worse outcomes. The present study seeks to evaluate the effect of a hybrid multidisciplinary intervention for implementing a healthy lifestyle to modify the personal and internal exposome of young women with breast cancer. This randomized controlled experimental study with two groups: Group 1: Hybrid multidisciplinary lifestyle education intervention. Group 2: Individualized hybrid multidisciplinary lifestyle interventions. The multidisciplinary lifestyle intervention program includes oncology, nutrition, physiotherapy, and psychology interventions.
Eligibility
Inclusion Criteria: * Women diagnosed with stage I-III BC, confirmed by pathology and image at the INCAN * Candidates for multidisciplinary treatment including surgery, chemotherapy, and/or hormonal treatments. * Signed the informed consent form * Have access to a mobile phone or any electronic device with an active internet connection to receive the program information. Exclusion Criteria: * Patients with inflammatory cancer * Those with cardiomyopathy or ventricular dysfunction (NYHA \>II), arrythmia secondary to left ventricular ejection alterations that requires medication, previous myocardial infarction, or angina pectoris in the last six months * Receiving treatment for cardiovascular or cerebrovascular disease, inflammatory bowel disease, malabsorption syndrome, rheumatoid arthritis, lupus, thyroid diseases, or Cushing syndrome * Unable to walk for at least 1 km * Have cardiovascular, respiratory, or musculoskeletal diseases that impede physical activity * Pregnant or breastfeeding * Have psychiatric conditions impeding active participation in this protocol * Do not understand Spanish
Conditions3
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT06090747